However, GLP-1 receptor agonists had no significant effects on the occurrence of thyroid cancer (RR 1.30, 95% CI 0.86-1.97), hyperthyroidism (RR 1.19, 95% CI 0.61-2.35), hypothyroidism (RR 1.22, 95% CI 0.80-1.87), thyroiditis (RR 1.83, 95% CI 0.51-6.57), thyroid mass (RR 1.17, 95% CI 0.43-3.20), and goiter (RR 1.17, 95% CI 0.74-1.86)
Jurcu MC, Andronie-Cioara FL, Jurcu A, Marcu F, i DM, Pacalu N, et al
These often ease with time and dose adjustments
Ideal under make-up too
Dmitrieva-Posocco, O
We stay updated on the latest techniques and industry standards to ensure safe, effective treatments